Abstract
Deferasirox is an oral iron chelator used widely in the treatment of thalassemia major and other transfusion-dependent hemoglobinopathies. Whilst initial long-term studies established the renal safety of deferasirox, there are now increasing reports of hypercalciuria and renal tubular dysfunction. In addition, urolithiasis with rapid loss of bone density in patients with β thalassemia major has been reported. We conducted a cross-sectional cohort study enrolling 152 adult patients comprising of β thalassemia major (81.5%), sickle cell disease (8%), thalassemia intermedia (2%), HbH disease (6.5%) and E/β thalassemia (2%). Cases were matched with normal control subjects on age, gender and serum creatinine. Iron chelator use was documented and urine calcium to creatinine ratios measured. At the time of analysis, 88.8% of patients were receiving deferasirox and 11.2% were on deferoxamine. Hypercalciuria was present in 91.9% of subjects on deferasirox in a positive dose-dependent relationship. This was not seen with subjects receiving deferoxamine. At a mean dose of 30.2±8.8mg/kg/day, deferasirox was associated with an almost 4 fold increase in urine calcium to creatinine ratio (UCa/Cr). Hypercalciuria was present at therapeutic dos...Continue Reading
References
May 1, 1969·Journal of Clinical Pathology·M R Wills
Nov 13, 2001·British Journal of Haematology·J B Porter
Feb 14, 2002·Archives of Biochemistry and Biophysics·Hani AtamnaBruce N Ames
Jun 14, 2002·Diabetes Research and Clinical Practice·David W DunstanUNKNOWN Australian Diabetes, Obesity and Lifestyle Study (AusDiab)
Dec 15, 2005·Blood·Maria Domenica CappelliniDaniele Alberti
Aug 19, 2007·Clinical Therapeutics·Maria Domenica CappelliniJean-Francois Baladi
Feb 4, 2009·European Journal of Haematology·Ali TaherAbdullah Al Jefri
Feb 27, 2010·Acta Haematologica·Marina EconomouMiranda Athanassiou-Metaxa
Feb 22, 2011·British Journal of Haematology·Charles T QuinnUNKNOWN Thalassemia Clinical Research Network
Jun 2, 2011·Blood·M Domenica CappelliniYesim Aydinok
Oct 1, 2011·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Frances MilatDonald K Bowden
Jun 13, 2012·European Journal of Haematology·Sunil Bhandari, Renzo Galanello
Aug 31, 2012·Annals of Hematology·Vlachaki EfthimiaVasileios Perifanis
Jan 8, 2013·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P WongF Milat
Jun 29, 2013·Annals of Hematology·Paolo RicchiLuciano Prossomariti
Aug 2, 2013·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P WongB J Strauss
Oct 19, 2013·Pediatric Hematology and Oncology·Majid NaderiTaregh Bamedi
Apr 26, 2014·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Phillip WongFrances Milat
Sep 14, 2014·Haematologica·Francesca RossiSabatino Maione
Citations
Aug 10, 2016·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·A D DedeS Tournis
Apr 6, 2019·Hematology·Christos DemosthenousPantelis Sarafidis
Dec 10, 2017·Hematology·Antonio Piga
Dec 12, 2017·Hemoglobin·Alessandro BaldanCaterina Borgna-Pignatti
Feb 15, 2017·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·A Morton
Sep 12, 2017·Internal Medicine Journal·Phillip WongKen K Lau
Sep 4, 2021·Endocrine Reviews·Peter R EbelingFrances Milat
Dec 7, 2018·Acta Haematologica·Huihong DouYanjun Zhao
May 21, 2020·Kidney & Blood Pressure Research·Giovanna CapolongoAldo Filosa